{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:35:42Z","timestamp":1793036142818,"version":"4.5.0"},"reference-count":59,"publisher":"BMJ","issue":"1","funder":[{"name":"Agency for Innovation by Science and Technology in Flanders"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Proton pump inhibitor (PPI) use is becoming increasingly common. Although the toxicity profiles of PPIs are not well understood particularly in children, PPIs have been associated with increased risks of gastrointestinal and respiratory tract infection, vitamin B<jats:sub>12<\/jats:sub> deficiency, hypomagnesaemia, bone fractures, and rebound hyperacidity after discontinuation. Prescribers should take into account that PPI uses pose toxicity risks, which remain to be fully characterised in infants and children.<\/jats:p>","DOI":"10.1136\/archdischild-2017-314026","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T12:50:29Z","timestamp":1513169429000},"page":"78-82","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":96,"title":["Toxicity of long-term use of proton pump inhibitors in children"],"prefix":"10.1136","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3090-9755","authenticated-orcid":false,"given":"Pauline","family":"De Bruyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"2020050712424285000_103.1.78.1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0012-x"},{"key":"2020050712424285000_103.1.78.2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MPG.0b013e3182a3b04e","article-title":"Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009]","volume":"58","author":"De Bruyne","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020050712424285000_103.1.78.3","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31812e0149"},{"key":"2020050712424285000_103.1.78.4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10620-007-9880-7","article-title":"Long-term proton pump inhibitor use in children: a retrospective review of safety","volume":"53","author":"Tolia","year":"2008","journal-title":"Dig Dis Sci"},{"key":"2020050712424285000_103.1.78.5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrgastro.2013.199","article-title":"Management of paediatric GERD","volume":"11","author":"Vandenplas","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2020050712424285000_103.1.78.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000361306.15727.54"},{"key":"2020050712424285000_103.1.78.7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4292\/wjgpt.v7.i4.531","article-title":"Widespread use of gastric acid inhibitors in infants: are they needed? are they safe?","volume":"7","author":"Safe","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"2020050712424285000_103.1.78.8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/phar.1299","article-title":"Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease","volume":"33","author":"Tjon","year":"2013","journal-title":"Pharmacotherapy"},{"key":"2020050712424285000_103.1.78.9","first-page":"283","article-title":"Proton pump inhibitor prescribing patterns in newborns and infants","volume":"19","author":"Illueca","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2020050712424285000_103.1.78.10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpeds.2016.03.059","article-title":"Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children\u2019s Hospitals","volume":"174","author":"Slaughter","year":"2016","journal-title":"J Pediatr"},{"key":"2020050712424285000_103.1.78.11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.86"},{"key":"2020050712424285000_103.1.78.12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bcp.12619","article-title":"Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review","volume":"80","author":"Cohen","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"2020050712424285000_103.1.78.13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1543"},{"key":"2020050712424285000_103.1.78.14","doi-asserted-by":"crossref","unstructured":"Stoll BJ , Temprosa M , Tyson JE , et al . Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999;104:e63.doi:10.1542\/peds.104.5.e63","DOI":"10.1542\/peds.104.5.e63"},{"key":"2020050712424285000_103.1.78.15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/00006454-199412000-00008","article-title":"Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study","volume":"13","author":"Beck-Sague","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"2020050712424285000_103.1.78.16","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200004000-00011"},{"key":"2020050712424285000_103.1.78.17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ432"},{"key":"2020050712424285000_103.1.78.18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310376"},{"key":"2020050712424285000_103.1.78.19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapediatrics.2014.696","article-title":"Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth","volume":"168","author":"Rosen","year":"2014","journal-title":"JAMA Pediatr"},{"key":"2020050712424285000_103.1.78.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01275.x"},{"key":"2020050712424285000_103.1.78.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04874.x"},{"key":"2020050712424285000_103.1.78.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.23.2989"},{"key":"2020050712424285000_103.1.78.23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1655"},{"key":"2020050712424285000_103.1.78.24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2036.2009.04229.x","article-title":"Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection","volume":"31","author":"Turco","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050712424285000_103.1.78.25","doi-asserted-by":"publisher","DOI":"10.1177\/0009922815569201"},{"key":"2020050712424285000_103.1.78.26","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.092129"},{"key":"2020050712424285000_103.1.78.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04284.x"},{"key":"2020050712424285000_103.1.78.28","doi-asserted-by":"crossref","unstructured":"Lambert AA , Lam JO , Paik JJ , et al . Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One 2015;10:e0128004.doi:10.1371\/journal.pone.0128004","DOI":"10.1371\/journal.pone.0128004"},{"key":"2020050712424285000_103.1.78.29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1155\/2008\/821385","article-title":"Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials","volume":"22","author":"Sultan","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"2020050712424285000_103.1.78.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.09.054"},{"key":"2020050712424285000_103.1.78.31","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181c2bf41"},{"key":"2020050712424285000_103.1.78.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.2035"},{"key":"2020050712424285000_103.1.78.33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/apt.12052","article-title":"Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial","volume":"36","author":"Fiocca","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2020050712424285000_103.1.78.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03127.x"},{"key":"2020050712424285000_103.1.78.35","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.052480"},{"key":"2020050712424285000_103.1.78.36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/00365521.2012.746395","article-title":"Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment","volume":"48","author":"L\u00f8drup","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"2020050712424285000_103.1.78.37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.81"},{"key":"2020050712424285000_103.1.78.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.03.058"},{"key":"2020050712424285000_103.1.78.39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.08.023"},{"key":"2020050712424285000_103.1.78.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2003.08.015"},{"key":"2020050712424285000_103.1.78.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03601.x"},{"key":"2020050712424285000_103.1.78.42","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328348a56a"},{"key":"2020050712424285000_103.1.78.43","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00198-015-3168-0","article-title":"Use of proton pump inhibitors is associated with fractures in young adults: a population-based study","volume":"26","author":"Freedberg","year":"2015","journal-title":"Osteoporos Int"},{"key":"2020050712424285000_103.1.78.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.04.025"},{"key":"2020050712424285000_103.1.78.45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ajcn\/81.1.154","article-title":"Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB\/c mice and humans","volume":"81","author":"Sch\u00f6ll","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"2020050712424285000_103.1.78.46","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.74"},{"key":"2020050712424285000_103.1.78.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03407.x"},{"key":"2020050712424285000_103.1.78.48","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3329"},{"key":"2020050712424285000_103.1.78.49","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140074"},{"key":"2020050712424285000_103.1.78.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00651.x"},{"key":"2020050712424285000_103.1.78.51","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.7193"},{"key":"2020050712424285000_103.1.78.52","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015121377"},{"key":"2020050712424285000_103.1.78.53","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200911030-00004"},{"key":"2020050712424285000_103.1.78.54","doi-asserted-by":"publisher","DOI":"10.2165\/11531320-000000000-00000"},{"key":"2020050712424285000_103.1.78.55","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0144-0"},{"key":"2020050712424285000_103.1.78.56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007964"},{"key":"2020050712424285000_103.1.78.57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1747-0803.2010.00461.x","article-title":"Platelet activity associated with concomitant use of clopidogrel and proton pump inhibitors in children with cardiovascular disease","volume":"5","author":"Pasquali","year":"2010","journal-title":"Congenit Heart Dis"},{"key":"2020050712424285000_103.1.78.58","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304559"},{"key":"2020050712424285000_103.1.78.59","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1871-9"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2017-314026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:10:46Z","timestamp":1601071846000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2017-314026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,13]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/archdischild-2017-314026"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2017-314026","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]}}}